Isolated hyperCKemia
Last updated 21 Feb 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Audio Version
- Add to preferred sources on Google
Isolated hyperCKemia is a condition characterised by elevated levels of an enzyme called creatine kinase in the blood. In affected individuals, levels of this enzyme are typically 3 to 10 times higher than normal. While elevated creatine kinase often accompanies various muscle diseases, individuals with isolated hyperCKemia have no muscle weakness or other symptoms. Some people with this condition have abnormalities of muscle cells that can be seen with a microscope, such as unusual variability in the size of muscle fibers, but these changes do not affect the function of the muscle.
Description
Isolated hyperCKemia is a condition characterised by elevated levels of an enzyme called creatine kinase in the blood. In affected individuals, levels of this enzyme are typically 3 to 10 times higher than normal. While elevated creatine kinase often accompanies various muscle diseases, individuals with isolated hyperCKemia have no muscle weakness or other symptoms. Some people with this condition have abnormalities of muscle cells that can be seen with a microscope, such as unusual variability in the size of muscle fibers, but these changes do not affect the function of the muscle.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Elevated serum CPK
Elevated serum creatine phosphokinase
H-CK
Idiopathic hyperCKemia
Idiopathic persistent elevation of serum creatine kinase
Related patient information and medicines
Patient information leaflet
Hyperparathyroidism
Hyperparathyroidism occurs when too much parathyroid hormone is released by the parathyroid glands in the neck. If you have primary or tertiary hyperparathyroidism and do develop symptoms, these are due to a high level of calcium in your blood (hypercalcaemia). However, in a very small number of people, it can be the result of an inherited.
Patient information leaflet
Myeloma
Myeloma is a cancer that affects cells, called plasma cells, in the bone marrow. Bone marrow is the spongy tissue at the centre of some bones that produces the body's blood cells. As the cancerous plasma cells fill the bone marrow, you are not able to make enough normal blood cells. This can cause... If you have any of these symptoms you need to.
Patient information leaflet
COVID-19
Continue to isolate if their symptoms are not improving at five days, until their symptoms are improving and they... Isolate for 10 days if they have had moderately severe COVID (causing shortness of breath or difficulty breathing). Isolate for at least 10 days, consult a doctor, and consider taking a viral test before ending isolation for people.
Patient information leaflet
Avoidant personality disorder
If symptoms are present, a mental healthcare professional (such as a psychologist or psychiatrist) will make a thorough assessment of the nature and severity of symptoms, the difficulties caused by the symptoms, whether the symptoms fit with a diagnosis of avoidant personality disorder, and whether there are any other associated mental or physical.
Patient information leaflet
SARS and MERS virus
A SARS-CoV-2 (CO. This spread rapidly and was declared a global pandemic in 2020. MERS was first recognised in the Middle East in 2012. Most of the initial infections were in the Middle East. However, by February 2018, the World Health Organization (WHO) had reported cases in many other countries. What is severe acute respiratory syndrome (SARS)..
Patient information leaflet
Ageing
Older age tends to bring with it unwelcome changes such as a greater risk of health problems and typical changes to appearance. As populations are living longer, the challenge is to avoid living longer in ill health, but instead to have longer lives which are happy and healthy. The ageing population Globally, populations are becoming older. That.
Further reading and references
- Isolated hyperCKemia; MedlinePlus, National Library of Medicine.
- Aboumousa A, Hoogendijk J, Charlton R, Barresi R, Herrmann R, Voit T, Hudson J, Roberts M, Hilton-Jones D, Eagle M, Bushby K, Straub V. Caveolinopathy--new mutations and additional symptoms. Neuromuscul Disord. 2008 Jul;18(7):572-8. doi: 10.1016/j.nmd.2008.05.003. Epub 2008 Jun 25.
- Alias L, Gallano P, Moreno D, Pujol R, Martinez-Matos JA, Baiget M, Ferrer I, Olive M. A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia. Neuromuscul Disord. 2004 May;14(5):321-4. doi: 10.1016/j.nmd.2004.01.006.
- Carbone I, Bruno C, Sotgia F, Bado M, Broda P, Masetti E, Panella A, Zara F, Bricarelli FD, Cordone G, Lisanti MP, Minetti C. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology. 2000 Mar 28;54(6):1373-6. doi: 10.1212/wnl.54.6.1373.
- Gazzerro E, Bonetto A, Minetti C. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders. Handb Clin Neurol. 2011;101:135-42. doi: 10.1016/B978-0-08-045031-5.00010-4.
- Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C. Caveolinopathies: from the biology of caveolin-3 to human diseases. Eur J Hum Genet. 2010 Feb;18(2):137-45. doi: 10.1038/ejhg.2009.103. Epub 2009 Jul 8.
- Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology. 2004 Feb 24;62(4):538-43. doi: 10.1212/wnl.62.4.538.
Join the conversation
Share your thoughts or experiences with others in our patient communities.
Ask, share, connect.
Browse discussions, ask questions, and share experiences across hundreds of health topics.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.